← All companies
Hold Current rating · 2 reports
Hold Recap: Q2 2026
Novartis Returns to Growth, Then Tells You Five Points of It Reverse in the Second Half
Hold Recap: Q4 2025
Novartis Clears the 40% Margin Bar Two Years Early, Then Guides to Its First Core Profit Decline in Five Years
The depth and quality Wall Street pays for — free.
Missed the earnings call? Don't miss our breakdown.